| A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia TR Docking, JDK Parker, M Jädersten, G Duns, L Chang, J Jiang, ... Nature Communications 12 (1), 2474, 2021 | 71 | 2021 |
| VEXAS syndrome in a female patient with constitutional 45, X (Turner syndrome) RJ Stubbins, E McGinnis, B Johal, LYC Chen, L Wilson, DO Cardona, ... Haematologica 107 (4), 1011, 2022 | 51 | 2022 |
| Differentiation therapy for myeloid malignancies: beyond cytotoxicity RJ Stubbins, A Karsan Blood cancer journal 11 (12), 193, 2021 | 44 | 2021 |
| Epstein‐Barr virus associated smooth muscle tumors in solid organ transplant recipients: incidence over 31 years at a single institution and review of the literature RJ Stubbins, N Alami Laroussi, AC Peters, S Urschel, F Dicke, RL Lai, ... Transplant Infectious Disease 21 (1), e13010, 2019 | 28 | 2019 |
| Management of acute myeloid leukemia: a review for general practitioners in oncology RJ Stubbins, A Francis, F Kuchenbauer, D Sanford Current oncology 29 (9), 6245-6259, 2022 | 27 | 2022 |
| Inflammation and myeloid malignancy: quenching the flame RJ Stubbins, U Platzbecker, A Karsan Blood, The Journal of the American Society of Hematology 140 (10), 1067-1074, 2022 | 26 | 2022 |
| Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies RJ Stubbins, S Korotev, LA Godley Current Hematologic Malignancy Reports 17 (4), 94-104, 2022 | 15 | 2022 |
| Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder MD Jain, R Lam, Z Liu, RJ Stubbins, A Kahlon, R Kansara, R Goswami, ... British Journal of Haematology 189 (1), 97-105, 2020 | 13 | 2020 |
| VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation H Cherniawsky, J Friedmann, H Nicolson, N Dehghan, RJ Stubbins, ... European Journal of Haematology 110 (6), 633-638, 2023 | 12 | 2023 |
| Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome RJ Stubbins, H Cherniawsky, LYC Chen, TJ Nevill Cmaj 194 (14), E524-E527, 2022 | 11 | 2022 |
| Mitochondrial metabolism: powering new directions in acute myeloid leukemia RJ Stubbins, IA Maksakova, DS Sanford, A Rouhi, F Kuchenbauer Leukemia & Lymphoma 62 (10), 2331-2341, 2021 | 9 | 2021 |
| Lost in translation: cytoplasmic UBA1 and VEXAS syndrome RJ Stubbins Blood, The Journal of the American Society of Hematology 140 (13), 1455-1457, 2022 | 7 | 2022 |
| Classic Hodgkin lymphoma post-transplant lymphoproliferative disorders (PTLD) are often preceded by discordant PTLD subtypes RJ Stubbins, C Mabilangan, M Rojas-Vasquez, RL Lai, J Zhu, ... Leukemia & Lymphoma 61 (14), 3319-3330, 2020 | 6 | 2020 |
| Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real‐world outcomes from a population‐based cohort RJ Stubbins, M Stamenkovic, C Roy, J Rodrigo, S Chung, ... European Journal of Haematology 108 (5), 437-445, 2022 | 5 | 2022 |
| Germline loss-of-function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies RJ Stubbins, AS Asom, P Wang, AM Lager, A Gary, LA Godley Haematologica 109 (1), 351, 2024 | 4 | 2024 |
| Clinical outcomes in fresh versus cryopreserved hematopoietic stem cell products in British Columbia: a retrospective study B Wan, L Lindo, G Cameron, Y Abou Mourad, S Chung, DL Forrest, ... Blood 140 (Supplement 1), 7555-7557, 2022 | 1 | 2022 |
| Tumor Infiltrating Lymphocytes Predict Survival in Solid Organ Transplant Recipients with Monomorphic Post-transplant Lymphoproliferative Disorders RJ Stubbins, R Lam, J Zhu, S Ghosh, C Mabilangan, J Kuruvilla, ... Clinical Lymphoma Myeloma and Leukemia 22 (10), 744-752, 2022 | 1 | 2022 |
| Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort S Ghosh, F Kuchenbauer, RJ Stubbins, S Chung, S Narayanan, TJ Nevill, ... Blood 142, 1482, 2023 | | 2023 |
| British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib S Chung, AK McEwan, Y Abou Mourad, DL Forrest, K Hay, ... Blood 142, 6972, 2023 | | 2023 |
| Real-World Outcomes of Pfts in Screening for Lung Involvement in Chronic Gvhd Post-Allogeneic Stem Cell Transplant: A Retrospective Study of 387 Patients in British Columbia … B Wan, Y Abou Mourad, S Chung, DL Forrest, F Kuchenbauer, SH Nantel, ... Blood 142, 3559, 2023 | | 2023 |
